Europe Solid Tumors Drugs Market Report 2016

Published: Sep, 2016 | Pages: 126 | Publisher: QYResearch
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Notes:
Sales, means the sales volume of Solid Tumors Drugs
Revenue, means the sales value of Solid Tumors Drugs

This report studies sales (consumption) of Solid Tumors Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
    Covidien llc (Medtronic)
    Johnson & Johnson MEDICAL
    Bolton Surgical
    Platts & Nisbett
    Frankenman International
    Changzhou Waston
    Jiangsu Qianjing Medical
    Changzhou Anker Medical
    Changzhou Tongchuang Medical
    Jiangsu Reable Medical
    Changzhou Resource Medical
    Jiangsu Kangjin Medical
    CTI BioPharma
    Chugai Pharmaceutical
    NewLink Genetics

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Solid Tumors Drugs in these countries, from 2011 to 2021 (forecast), like
    Germany
    France
    UK
    Russia
    Italy
    Spain
    Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
    Type I
    Type II
    Type III
Split by application, this report focuses on sales, market share and growth rate of  Solid Tumors Drugs in each application, can be divided into
    Application 1
    Application 2
    Application 3

 Table of Contents


Europe Solid Tumors Drugs Market Report 2016
1 Solid Tumors Drugs Overview
    1.1 Product Overview and Scope of Solid Tumors Drugs
    1.2 Classification of Solid Tumors Drugs
        1.2.1 Type I
        1.2.2 Type II
        1.2.3 Type III
    1.3 Application of Solid Tumors Drugs
        1.3.1 Application 1
        1.3.2 Application 2
        1.3.3 Application 3
    1.4 Solid Tumors Drugs Market by Countries
        1.4.1 Germany Status and Prospect (2011-2021)
        1.4.2 France Status and Prospect (2011-2021)
        1.4.3 UK Status and Prospect (2011-2021)
        1.4.4 Russia Status and Prospect (2011-2021)
        1.4.5 Italy Status and Prospect (2011-2021)
        1.4.6 Spain Status and Prospect (2011-2021)
        1.4.7 Benelux Status and Prospect (2011-2021)
    1.5 Europe Market Size (Value and Volume) of Solid Tumors Drugs (2011-2021)
        1.5.1 Europe Solid Tumors Drugs Sales and Growth Rate (2011-2021)
        1.5.2 Europe Solid Tumors Drugs Revenue and Growth Rate (2011-2021)

2 Europe Solid Tumors Drugs by Manufacturers, Type and Application
    2.1 Europe Solid Tumors Drugs Market Competition by Manufacturers
        2.1.1 Europe Solid Tumors Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
        2.1.2 Europe Solid Tumors Drugs Revenue and Share by Manufacturers (2015 and 2016)
    2.2 Europe Solid Tumors Drugs (Volume and Value) by Type
        2.2.1 Europe Solid Tumors Drugs Sales and Market Share by Type (2011-2016)
        2.2.2 Europe Solid Tumors Drugs Revenue and Market Share by Type (2011-2016)
    2.3 Europe Solid Tumors Drugs (Volume and Value) by Countries
        2.3.1 Europe Solid Tumors Drugs Sales and Market Share by Countries (2011-2016)
        2.3.2 Europe Solid Tumors Drugs Revenue and Market Share by Countries (2011-2016)
    2.4 Europe Solid Tumors Drugs (Volume) by Application

3 Germany Solid Tumors Drugs (Volume, Value and Sales Price)
    3.1 Germany Solid Tumors Drugs Sales and Value (2011-2016)
        3.1.1 Germany Solid Tumors Drugs Sales and Growth Rate (2011-2016)
        3.1.2 Germany Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
        3.1.3 Germany Solid Tumors Drugs Sales Price Trend (2011-2016)
    3.2 Germany Solid Tumors Drugs Sales and Market Share by Manufacturers
    3.3 Germany Solid Tumors Drugs Sales and Market Share by Type
    3.4 Germany Solid Tumors Drugs Sales and Market Share by Application

4 France Solid Tumors Drugs (Volume, Value and Sales Price)
    4.1 France Solid Tumors Drugs Sales and Value (2011-2016)
        4.1.1 France Solid Tumors Drugs Sales and Growth Rate (2011-2016)
        4.1.2 France Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
        4.1.4 France Solid Tumors Drugs Sales Price Trend (2011-2016)
    4.2 France Solid Tumors Drugs Sales and Market Share by Manufacturers
    4.3 France Solid Tumors Drugs Sales and Market Share by Type
    4.4 France Solid Tumors Drugs Sales and Market Share by Application

5 UK Solid Tumors Drugs (Volume, Value and Sales Price)
    5.1 UK Solid Tumors Drugs Sales and Value (2011-2016)
        5.1.1 UK Solid Tumors Drugs Sales and Growth Rate (2011-2016)
        5.1.2 UK Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
        5.1.5 UK Solid Tumors Drugs Sales Price Trend (2011-2016)
    5.2 UK Solid Tumors Drugs Sales and Market Share by Manufacturers
    5.3 UK Solid Tumors Drugs Sales and Market Share by Type
    5.4 UK Solid Tumors Drugs Sales and Market Share by Application

6 Russia Solid Tumors Drugs (Volume, Value and Sales Price)
    6.1 Russia Solid Tumors Drugs Sales and Value (2011-2016)
        6.1.1 Russia Solid Tumors Drugs Sales and Growth Rate (2011-2016)
        6.1.2 Russia Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
        6.1.6 Russia Solid Tumors Drugs Sales Price Trend (2011-2016)
    6.2 Russia Solid Tumors Drugs Sales and Market Share by Manufacturers
    6.3 Russia Solid Tumors Drugs Sales and Market Share by Type
    6.4 Russia Solid Tumors Drugs Sales and Market Share by Application

7 Italy Solid Tumors Drugs (Volume, Value and Sales Price)
    7.1 Italy Solid Tumors Drugs Sales and Value (2011-2016)
        7.1.1 Italy Solid Tumors Drugs Sales and Growth Rate (2011-2016)
        7.1.2 Italy Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
        7.1.7 Italy Solid Tumors Drugs Sales Price Trend (2011-2016)
    7.2 Italy Solid Tumors Drugs Sales and Market Share by Manufacturers
    7.3 Italy Solid Tumors Drugs Sales and Market Share by Type
    7.4 Italy Solid Tumors Drugs Sales and Market Share by Application

8 Spain Solid Tumors Drugs (Volume, Value and Sales Price)
    8.1 Spain Solid Tumors Drugs Sales and Value (2011-2016)
        8.1.1 Spain Solid Tumors Drugs Sales and Growth Rate (2011-2016)
        8.1.2 Spain Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
        8.1.8 Spain Solid Tumors Drugs Sales Price Trend (2011-2016)
    8.2 Spain Solid Tumors Drugs Sales and Market Share by Manufacturers
    8.3 Spain Solid Tumors Drugs Sales and Market Share by Type
    8.4 Spain Solid Tumors Drugs Sales and Market Share by Application

9 Benelux Solid Tumors Drugs (Volume, Value and Sales Price)
    9.1 Benelux Solid Tumors Drugs Sales and Value (2011-2016)
        9.1.1 Benelux Solid Tumors Drugs Sales and Growth Rate (2011-2016)
        9.1.2 Benelux Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
        9.1.9 Benelux Solid Tumors Drugs Sales Price Trend (2011-2016)
    9.2 Benelux Solid Tumors Drugs Sales and Market Share by Manufacturers
    9.3 Benelux Solid Tumors Drugs Sales and Market Share by Type
    9.4 Benelux Solid Tumors Drugs Sales and Market Share by Application

10 Europe Solid Tumors Drugs Manufacturers Analysis
    10.1 Covidien llc (Medtronic)
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Solid Tumors Drugs Product Type, Application and Specification
            10.1.2.1 Type I
            10.1.2.2 Type II
        10.1.3 Covidien llc (Medtronic) Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        10.1.4 Main Business/Business Overview
    10.2 Johnson & Johnson MEDICAL
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Solid Tumors Drugs Product Type, Application and Specification
            10.2.2.1 Type I
            10.2.2.2 Type II
        10.2.3 Johnson & Johnson MEDICAL Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        10.2.4 Main Business/Business Overview
    10.3 Bolton Surgical
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Solid Tumors Drugs Product Type, Application and Specification
            10.3.2.1 Type I
            10.3.2.2 Type II
        10.3.3 Bolton Surgical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        10.3.4 Main Business/Business Overview
    10.4 Platts & Nisbett
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Solid Tumors Drugs Product Type, Application and Specification
            10.4.2.1 Type I
            10.4.2.2 Type II
        10.4.3 Platts & Nisbett Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        10.4.4 Main Business/Business Overview
    10.5 Frankenman International
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Solid Tumors Drugs Product Type, Application and Specification
            10.5.2.1 Type I
            10.5.2.2 Type II
        10.5.3 Frankenman International Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        10.5.4 Main Business/Business Overview
    10.6 Changzhou Waston
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Solid Tumors Drugs Product Type, Application and Specification
            10.6.2.1 Type I
            10.6.2.2 Type II
        10.6.3 Changzhou Waston Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        10.6.4 Main Business/Business Overview
    10.7 Jiangsu Qianjing Medical
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Solid Tumors Drugs Product Type, Application and Specification
            10.7.2.1 Type I
            10.7.2.2 Type II
        10.7.3 Jiangsu Qianjing Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        10.7.4 Main Business/Business Overview
    10.8 Changzhou Anker Medical
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Solid Tumors Drugs Product Type, Application and Specification
            10.8.2.1 Type I
            10.8.2.2 Type II
        10.8.3 Changzhou Anker Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        10.8.4 Main Business/Business Overview
    10.9 Changzhou Tongchuang Medical
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Solid Tumors Drugs Product Type, Application and Specification
            10.9.2.1 Type I
            10.9.2.2 Type II
        10.9.3 Changzhou Tongchuang Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        10.9.4 Main Business/Business Overview
    10.10 Jiangsu Reable Medical
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Solid Tumors Drugs Product Type, Application and Specification
            10.10.2.1 Type I
            10.10.2.2 Type II
        10.10.3 Jiangsu Reable Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
        10.10.4 Main Business/Business Overview
    10.11 Changzhou Resource Medical
    10.12 Jiangsu Kangjin Medical
    10.13 CTI BioPharma
    10.14 Chugai Pharmaceutical
    10.15 NewLink Genetics

11 Solid Tumors Drugs Manufacturing Cost Analysis
    11.1 Solid Tumors Drugs Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Solid Tumors Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Solid Tumors Drugs Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Europe Solid Tumors Drugs Market Forecast (2016-2021)
    14.1 Germany Solid Tumors Drugs Sales Forecast (2016-2021)
    14.2 France Solid Tumors Drugs Sales Forecast (2016-2021)
    14.3 UK Solid Tumors Drugs Sales Forecast (2016-2021)
    14.4 Russia Solid Tumors Drugs Sales Forecast (2016-2021)
    14.5 Italy Solid Tumors Drugs Sales Forecast (2016-2021)
    14.6 Spain Solid Tumors Drugs Sales Forecast (2016-2021)
    14.7 Benelux Solid Tumors Drugs Sales Forecast (2016-2021)
    14.8 Europe Solid Tumors Drugs Sales Forecast by Type (2016-2021)
    14.9 Europe Solid Tumors Drugs Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix
    Author List
    Disclosure Section
    Research Methodology
    Data Source
    Disclaimer

List of Tables and Figures


    Figure Picture of Solid Tumors Drugs
    Table Classification of Solid Tumors Drugs
    Figure Europe Sales Market Share of Solid Tumors Drugs by Type in 2015
    Figure Type I Picture
    Figure Type II Picture
    Table Application of Solid Tumors Drugs
    Figure Europe Sales Market Share of Solid Tumors Drugs by Application in 2015
    Figure Application 1 Examples
    Figure Application 2 Examples
    Figure Germany Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
    Figure France Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
    Figure UK Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
    Figure Russia Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
    Figure Italy Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
    Figure Spain Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
    Figure Benelux Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
    Figure Europe Solid Tumors Drugs Sales and Growth Rate (2011-2021)
    Figure Europe Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
    Table Europe Solid Tumors Drugs Sales of Key Manufacturers (2015 and 2016)
    Table Europe Solid Tumors Drugs Sales Share by Manufacturers (2015 and 2016)
    Figure 2015 Solid Tumors Drugs Sales Share by Manufacturers
    Figure 2016 Solid Tumors Drugs Sales Share by Manufacturers
    Table Europe Solid Tumors Drugs Revenue by Manufacturers (2015 and 2016)
    Table Europe Solid Tumors Drugs Revenue Share by Manufacturers (2015 and 2016)
    Table 2015 Europe Solid Tumors Drugs Revenue Share by Manufacturers
    Table 2016 Europe Solid Tumors Drugs Revenue Share by Manufacturers
    Table Europe Solid Tumors Drugs Sales and Market Share by Type (2011-2016)
    Table Europe Solid Tumors Drugs Sales Share by Type (2011-2016)
    Figure Sales Market Share of Solid Tumors Drugs by Type (2011-2016)
    Figure Europe Solid Tumors Drugs Sales Growth Rate by Type (2011-2016)
    Table Europe Solid Tumors Drugs Revenue and Market Share by Type (2011-2016)
    Table Europe Solid Tumors Drugs Revenue Share by Type (2011-2016)
    Figure Revenue Market Share of Solid Tumors Drugs by Type (2011-2016)
    Figure Europe Solid Tumors Drugs Revenue Growth Rate by Type (2011-2016)
    Table Europe Solid Tumors Drugs Sales and Market Share by Countries (2011-2016)
    Table Europe Solid Tumors Drugs Sales Share by Countries (2011-2016)
    Figure Sales Market Share of Solid Tumors Drugs by Countries (2011-2016)
    Table Europe Solid Tumors Drugs Revenue and Market Share by Countries (2011-2016)
    Table Europe Solid Tumors Drugs Revenue Share by Countries (2011-2016)
    Figure Revenue Market Share of Solid Tumors Drugs by Countries (2011-2016)
    Table Europe Solid Tumors Drugs Sales and Market Share by Application (2011-2016)
    Table Europe Solid Tumors Drugs Sales Share by Application (2011-2016)
    Figure Sales Market Share of Solid Tumors Drugs by Application (2011-2016)
    Figure Germany Solid Tumors Drugs Sales and Growth Rate (2011-2016)
    Figure Germany Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
    Figure Germany Solid Tumors Drugs Sales Price Trend (2011-2016)
    Table Germany Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)
    Table Germany Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)
    Table Germany Solid Tumors Drugs Sales by Type (2015 and 2016)
    Table Germany Solid Tumors Drugs Market Share by Type (2015 and 2016)
    Table Germany Solid Tumors Drugs Sales by Application (2015 and 2016)
    Table Germany Solid Tumors Drugs Market Share by Application (2015 and 2016)
    Figure France Solid Tumors Drugs Sales and Growth Rate (2011-2016)
    Figure France Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
    Figure France Solid Tumors Drugs Sales Price Trend (2011-2016)
    Table France Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)
    Table France Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)
    Table France Solid Tumors Drugs Sales by Type (2015 and 2016)
    Table France Solid Tumors Drugs Market Share by Type (2015 and 2016)
    Table France Solid Tumors Drugs Sales by Application (2015 and 2016)
    Table France Solid Tumors Drugs Market Share by Application (2015 and 2016)
    Figure UK Solid Tumors Drugs Sales and Growth Rate (2011-2016)
    Figure UK Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
    Figure UK Solid Tumors Drugs Sales Price Trend (2011-2016)
    Table UK Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)
    Table UK Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)
    Table UK Solid Tumors Drugs Sales by Type (2015 and 2016)
    Table UK Solid Tumors Drugs Market Share by Type (2015 and 2016)
    Table UK Solid Tumors Drugs Sales by Application (2015 and 2016)
    Table UK Solid Tumors Drugs Market Share by Application (2015 and 2016)
    Figure Russia Solid Tumors Drugs Sales and Growth Rate (2011-2016)
    Figure Russia Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
    Figure Russia Solid Tumors Drugs Sales Price Trend (2011-2016)
    Table Russia Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)
    Table Russia Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)
    Table Russia Solid Tumors Drugs Sales by Type (2015 and 2016)
    Table Russia Solid Tumors Drugs Market Share by Type (2015 and 2016)
    Table Russia Solid Tumors Drugs Sales by Application (2015 and 2016)
    Table Russia Solid Tumors Drugs Market Share by Application (2015 and 2016)
    Figure Italy Solid Tumors Drugs Sales and Growth Rate (2011-2016)
    Figure Italy Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
    Figure Italy Solid Tumors Drugs Sales Price Trend (2011-2016)
    Table Italy Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)
    Table Italy Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)
    Table Italy Solid Tumors Drugs Sales by Type (2015 and 2016)
    Table Italy Solid Tumors Drugs Market Share by Type (2015 and 2016)
    Table Italy Solid Tumors Drugs Sales by Application (2015 and 2016)
    Table Italy Solid Tumors Drugs Market Share by Application (2015 and 2016)
    Figure Spain Solid Tumors Drugs Sales and Growth Rate (2011-2016)
    Figure Spain Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
    Figure Spain Solid Tumors Drugs Sales Price Trend (2011-2016)
    Table Spain Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)
    Table Spain Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)
    Table Spain Solid Tumors Drugs Sales by Type (2015 and 2016)
    Table Spain Solid Tumors Drugs Market Share by Type (2015 and 2016)
    Table Spain Solid Tumors Drugs Sales by Application (2015 and 2016)
    Table Spain Solid Tumors Drugs Market Share by Application (2015 and 2016)
    Figure Benelux Solid Tumors Drugs Sales and Growth Rate (2011-2016)
    Figure Benelux Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
    Figure Benelux Solid Tumors Drugs Sales Price Trend (2011-2016)
    Table Benelux Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)
    Table Benelux Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)
    Table Benelux Solid Tumors Drugs Sales by Type (2015 and 2016)
    Table Benelux Solid Tumors Drugs Market Share by Type (2015 and 2016)
    Table Benelux Solid Tumors Drugs Sales by Application (2015 and 2016)
    Table Benelux Solid Tumors Drugs Market Share by Application (2015 and 2016)
    Table Solid Tumors Drugs Basic Information List
    Table Covidien llc (Medtronic) Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Figure Covidien llc (Medtronic) Solid Tumors Drugs Sales Market Share (2011-2016)
    Table Johnson & Johnson MEDICAL Basic Information List
    Table Johnson & Johnson MEDICAL Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Table Johnson & Johnson MEDICAL Solid Tumors Drugs Sales Market Share (2011-2016)
    Table Bolton Surgical Basic Information List
    Table Bolton Surgical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Table Bolton Surgical Solid Tumors Drugs Sales Market Share (2011-2016)
    Table Platts & Nisbett Basic Information List
    Table Platts & Nisbett Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Table Platts & Nisbett Solid Tumors Drugs Sales Market Share (2011-2016)
    Table Frankenman International Basic Information List
    Table Frankenman International Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Table Frankenman International Solid Tumors Drugs Sales Market Share (2011-2016)
    Table Changzhou Waston Basic Information List
    Table Changzhou Waston Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Table Changzhou Waston Solid Tumors Drugs Sales Market Share (2011-2016)
    Table Jiangsu Qianjing Medical Basic Information List
    Table Jiangsu Qianjing Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Table Jiangsu Qianjing Medical Solid Tumors Drugs Sales Market Share (2011-2016)
    Table Changzhou Anker Medical Basic Information List
    Table Changzhou Anker Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Table Changzhou Anker Medical Solid Tumors Drugs Sales Market Share (2011-2016)
    Table Changzhou Tongchuang Medical Basic Information List
    Table Changzhou Tongchuang Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Table Changzhou Tongchuang Medical Solid Tumors Drugs Sales Market Share (2011-2016)
    Table Jiangsu Reable Medical Basic Information List
    Table Jiangsu Reable Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Table Jiangsu Reable Medical Solid Tumors Drugs Sales Market Share (2011-2016)
    Table Changzhou Resource Medical Basic Information List
    Table Changzhou Resource Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Table Changzhou Resource Medical Solid Tumors Drugs Sales Market Share (2011-2016)
    Table Jiangsu Kangjin Medical Basic Information List
    Table Jiangsu Kangjin Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Table Jiangsu Kangjin Medical Solid Tumors Drugs Sales Market Share (2011-2016)
    Table CTI BioPharma Basic Information List
    Table CTI BioPharma Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Table CTI BioPharma Solid Tumors Drugs Sales Market Share (2011-2016)
    Table Chugai Pharmaceutical Basic Information List
    Table Chugai Pharmaceutical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Table Chugai Pharmaceutical Solid Tumors Drugs Sales Market Share (2011-2016)
    Table NewLink Genetics Basic Information List
    Table NewLink Genetics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
    Table NewLink Genetics Solid Tumors Drugs Sales Market Share (2011-2016)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Solid Tumors Drugs
    Figure Manufacturing Process Analysis of Solid Tumors Drugs
    Figure Solid Tumors Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
    Table Major Buyers of Solid Tumors Drugs
    Table Distributors/Traders List
    Figure Germany Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)
    Figure Germany Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
    Figure France Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)
    Figure France Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
    Figure UK Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)
    Figure UK Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
    Figure Russia Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)
    Figure Russia Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
    Figure Italy Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)
    Figure Italy Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
    Figure Spain Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)
    Figure Spain Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
    Figure Benelux Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)
    Figure Benelux Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
    Table Europe Solid Tumors Drugs Sales Forecast by Type (2016-2021)
    Table Europe Solid Tumors Drugs Sales Forecast by Application (2016-2021)

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.